| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Garvan Institute of Medical Research (T.V.N., J.R.C., J.A.E.), Sydney, New South Wales 2010, Australia; and Department of Anatomy and Anthropology, Tel Aviv University (G.L., K.Y.), Tel Aviv 69978, Israel
Address all correspondence and requests for reprints to: Dr Tuan V. Nguyen, Bone and Mineral Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, Australia. E-mail: t.nguyen{at}garvan.org.au.
This study was designed to test the hypothesis of a major gene influence on the variation in bone mineral density (BMD). BMD and bone mineral content at the lumbar spine and femoral neck were measured in 330 men and 413 women, aged 1890 yr, from 107 nuclear and complex families (including 5 large pedigrees with 194 individuals who were identified through an index case with moderately high BMD at the femoral neck (z-score,
1.28)). After adjusting for age and body weight, familial factors accounted for up to 72% of the total variation in BMD. In complex segregation analysis, for all variables examined the best-fitting most parsimonious model consistently suggested the Mendelian transmission of a major gene locus with significant residual correlations among siblings. This genetic model suggested that the proportion of a total variance (adjusted for significant covariates) attributable to a putative major gene effect ranged between 0.30 ± 0.09 for femoral neck BMD and 0.53 ± 0.07 for the principal component obtained on BMD and corresponding bone mineral content measures. These findings clearly support the hypothesis that a large component of the variance in BMD is under genetic control, with strong evidence for a major gene locus influencing BMD transmission.
This work was supported by the National Health and Medical Research Council of Australia.
Abbreviations: BMC, Bone mineral content; BMD, bone mineral density; DOES, Dubbo Osteoporosis Epidemiology Study; DOGS, Dubbo Osteoporosis Epidemiology Study; FN, femoral neck; LS, lumbar spine; MG, major gene.
This article has been cited by other articles:
![]() |
L. S. H. Nissen-Meyer, R. Jemtland, V. T. Gautvik, M. E. Pedersen, R. Paro, D. Fortunati, D. D. Pierroz, V. A. Stadelmann, S. Reppe, F. P. Reinholt, et al. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice J. Cell Sci., August 15, 2007; 120(16): 2785 - 2795. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Nguyen, J. A. Eisman, J. R. Center, and T. V. Nguyen Risk Factors for Fracture in Nonosteoporotic Men and Women J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peacock, D. L. Koller, T. Fishburn, S. Krishnan, D. Lai, S. Hui, C. C. Johnston, T. Foroud, and M. J. Econs Sex-Specific and Non-Sex-Specific Quantitative Trait Loci Contribute to Normal Variation in Bone Mineral Density in Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3060 - 3066. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |